journal article·2018

Enhanced cellular uptake by non-endocytic pathway for tumor therapy

Yanxi Liu, Qiuyi Li, Xiaofeng Xiong, Yuan Huang, Zhou Zhou

Journal of Materials Chemistry B· Volume 6· Issue 45
Publisher page

Abstract

Endosome/lysosome, as the potential risk of therapeutic inactivation resulting from physical obstruction and a number of acid hydrolases, is a bottleneck in effective intracellular delivery which needs to be overcome. One promising strategy to avoid this barrier is to deliver therapeutic agents directly into the cytoplasm. In this study, CLIP6 peptide (KVRVRVRVDPPTRVRERVK-NH2) which can facilitate non-endosomal cell entry and anticancer drug doxorubicin (DOX) were covalently grafted to N-(2-hydroxypropyl)methacrylamide (HPMA) backbone (P-DOX-CLIP6). As a result, CLIP6 peptide modification increased the cellular uptake of DOX-loaded HPMA copolymers. Importantly, it effectively reduced lysosomal accumulation, leading to stronger proliferation inhibition and superior growth inhibition effect on three-dimensional tumor spheroids, compared to unmodified HPMA copolymer conjugates. Furthermore, P-CLIP6-DOX induced the highest therapeutic efficacy in HeLa tumor-bearing nude mice. Meanwhile, no significant systemic toxicity was observed during the treatment. In conclusion, this study provided a promising strategy to efficiently deliver drug candidates which were limited by endo/lysosomal trapping.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Nanoparticle-Based Drug Delivery · Cell Adhesion Molecules Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Drug Targeting and Drug Delivery System

Ministry of Education

West China School of Pharmacy

Sichuan University

Chengdu 610041

Funding

National Natural Science Foundation of China

References (34)

Show source-provided references
1. Paillard · Biomaterials · 2010 · 31 · 754210.1016/j.biomaterials.2010.06.024 ↗
2. Panyam · FASEB J. · 2002 · 16 · 121710.1096/fj.02-0088com ↗
3. Wattiaux · Adv. Drug Delivery Rev. · 2000 · 41 · 20110.1016/S0169-409X(99)00066-6 ↗
4. Mollenhauer · Biochim. Biophys. Acta, Rev. Biomembr. · 1990 · 1031 · 22510.1016/0304-4157(90)90008-Z ↗
5. De Duve · Biochem. Pharmacol. · 1974 · 23 · 249510.1016/0006-2952(74)90174-9 ↗
6. Lee · J. Controlled Release · 2008 · 129 · 22810.1016/j.jconrel.2008.04.024 ↗
7. Lee · Nano Lett. · 2005 · 5 · 32510.1021/nl0479987 ↗
8. Tanaka · Int. J. Pharm. · 2010 · 398 · 21910.1016/j.ijpharm.2010.07.038 ↗
9. Partlow · Biomaterials · 2008 · 29 · 336710.1016/j.biomaterials.2008.04.030 ↗
10. Lee · Nano Lett. · 2012 · 12 · 632210.1021/nl303421h ↗
11. Kostarelos · Nat. Nanotechnol. · 2007 · 2 · 10810.1038/nnano.2006.209 ↗
12. El-Sayed · AAPS J. · 2009 · 11 · 1310.1208/s12248-008-9071-2 ↗
13. Li · Drug Delivery · 2017 · 24 · 4510.1080/10717544.2017.1391889 ↗
14. Barry · Biotechniques · 1993 · 15 · 1020
15. Leonetti · Proc. Natl. Acad. Sci. U. S. A. · 1991 · 88 · 270210.1073/pnas.88.7.2702 ↗
16. Bergan · Nucleic Acids Res. · 1993 · 21 · 356710.1093/nar/21.15.3567 ↗
17. Khalil · Pharmacol. Rev. · 2006 · 58 · 3210.1124/pr.58.1.8 ↗
18. Medina · Angew. Chem. · 2016 · 128 · 343010.1002/ange.201510518 ↗
19. Lu · Adv. Drug Delivery Rev. · 2010 · 62 · 24610.1016/j.addr.2009.12.007 ↗
20. Kopeček · Adv. Drug Delivery Rev. · 2013 · 65 · 4910.1016/j.addr.2012.10.014 ↗
21. Ulbrich · J. Controlled Release · 2000 · 64 · 6310.1016/S0168-3659(99)00141-8 ↗
22. Liu · Pharm. Res. · 2008 · 25 · 291010.1007/s11095-008-9683-3 ↗
23. Han · J. Controlled Release · 2012 · 163 · 13610.1016/j.jconrel.2012.08.020 ↗
24. Geering · Mol. Cell. Biol. · 2016 · 36 · 13210.1128/MCB.00515-15 ↗
25. Du · Biomacromolecules · 2015 · 16 · 147010.1021/acs.biomac.5b00282 ↗
26. Carvalho · Curr. Med. Chem. · 2009 · 16 · 326710.2174/092986709788803312 ↗
27. Fan · Int. J. Environ. Res. Public Health · 2012 · 9 · 473210.3390/ijerph9124732 ↗
28. Şener · Food Chem. Toxicol. · 2007 · 45 · 54310.1016/j.fct.2006.07.024 ↗
29. Wang · Toxicol. Lett. · 2007 · 168 · 17610.1016/j.toxlet.2006.12.001 ↗
30. McElroy · J. Infect. Dis. · 2014 · 210 · 55810.1093/infdis/jiu088 ↗
31. Wu · Arch. Pathol. Lab. Med. · 2016 · 140 · 138310.5858/arpa.2015-0454-OA ↗
32. Charriaut-Marlangue · NeuroReport · 1995 · 7 · 6110.1097/00001756-199512000-00014 ↗
33. Hartmann · Proc. Natl. Acad. Sci. U. S. A. · 2000 · 97 · 287510.1073/pnas.040556597 ↗
34. Bryant · Histopathol.: Rev. Recent Adv. · 2006 · 48 · 50510.1111/j.1365-2559.2006.02378.x ↗